Quantification of Visual Field Loss in Age-related Macular Degeneration

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Jul 7

PMID 22768178

Citations 14

Authors

Jennifer H Acton

Jonathan M Gibson

Robert P Cubbidge

Affiliations

Soon will be listed here.

Abstract

Background: An evaluation of standard automated perimetry (SAP) and short wavelength automated perimetry (SWAP) for the central 10-2 visual field test procedure in patients with age-related macular degeneration (AMD) is presented in order to determine methods of quantifying the central sensitivity loss in patients at various stages of AMD.

Methods: 10-2 SAP and SWAP Humphrey visual fields and stereoscopic fundus photographs were collected in 27 eyes of 27 patients with AMD and 22 eyes of 22 normal subjects.

Results: Mean Deviation and Pattern Standard Deviation (PSD) varied significantly with stage of disease in SAP (both p<0.001) and SWAP (both p<0.001), but post hoc analysis revealed overlap of functional values among stages. In SWAP, indices of focal loss were more sensitive to detecting differences in AMD from normal. SWAP defects were greater in depth and area than those in SAP. Central sensitivity (within 1°) changed by -3.9 and -4.9 dB per stage in SAP and SWAP, respectively. Based on defect maps, an AMD Severity Index was derived.

Conclusions: Global indices of focal loss were more sensitive to detecting early stage AMD from normal. The SWAP sensitivity decline with advancing stage of AMD was greater than in SAP. A new AMD Severity Index quantifies visual field defects on a continuous scale. Although not all patients are suitable for SWAP examinations, it is of value as a tool in research studies of visual loss in AMD.

Citing Articles

Clinical efficacy of a head-mounted device for central vision loss.

Gu X, Wang Y, Zhao Q, Zhao X, Chen Y Sci Rep. 2024; 14(1):21384.

PMID: 39271764 PMC: 11399288. DOI: 10.1038/s41598-024-72331-0.

Investigating the Spatiotemporal Summation of Perimetric Stimuli in Dry Age-Related Macular Degeneration.

Hunter A, Anderson R, Redmond T, Garway-Heath D, Mulholland P Transl Vis Sci Technol. 2023; 12(11):37.

PMID: 38019498 PMC: 10691387. DOI: 10.1167/tvst.12.11.37.

Does outer retinal layer thickness correlate with the central visual field indices in early dry age-related macular degeneration?.

Acharya S, Kharel Sitaula R, Karki P, Mishra S, Dahal H, Poudel A Taiwan J Ophthalmol. 2023; 12(4):437-443.

PMID: 36660124 PMC: 9843572. DOI: 10.4103/tjo.tjo_29_22.

Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Shah S, Boopathiraj N, Starr M, Dalvin L, AbouChehade J, Damento G Am J Ophthalmol. 2022; 243:98-108.

PMID: 35932820 PMC: 10107401. DOI: 10.1016/j.ajo.2022.07.025.

Low Light Exposure and Physical Activity in Older Adults With and Without Age-Related Macular Degeneration.

Dev M, Black A, Cuda D, Wood J Transl Vis Sci Technol. 2022; 11(3):21.

PMID: 35311931 PMC: 8944400. DOI: 10.1167/tvst.11.3.21.

References

Conway M, Cubbidge R, Hosking S . Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy. Epilepsia. 2008; 49(1):108-16. DOI: 10.1111/j.1528-1167.2007.01249.x. View

Sample P, Martinez G, Weinreb R . Short-wavelength automated perimetry without lens density testing. Am J Ophthalmol. 1994; 118(5):632-41. DOI: 10.1016/s0002-9394(14)76578-x. View

Anderson A, Johnson C, Werner J . Measuring visual function in age-related macular degeneration with frequency-doubling (matrix) perimetry. Optom Vis Sci. 2011; 88(7):806-15. PMC: 3132570. DOI: 10.1097/OPX.0b013e31821861bd. View

Cheng A, Vingrys A . Visual losses in early age-related maculopathy. Optom Vis Sci. 1993; 70(2):89-96. DOI: 10.1097/00006324-199302000-00001. View

van Leeuwen R, Klaver C, Vingerling J, Hofman A, de Jong P . The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003; 121(4):519-26. DOI: 10.1001/archopht.121.4.519. View

Eisner A, Fleming S, Klein M, Mauldin W . Sensitivities in older eyes with good acuity: eyes whose fellow eye has exudative AMD. Invest Ophthalmol Vis Sci. 1987; 28(11):1832-7. View

Hudson C, Flanagan J, Turner G, Chen H, Young L, McLeod D . Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema. Diabetologia. 1998; 41(8):918-28. DOI: 10.1007/s001250051008. View

Li J, Tso M, Lam T . Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration. Br J Ophthalmol. 2001; 85(3):287-90. PMC: 1723891. DOI: 10.1136/bjo.85.3.287. View

Bengtsson B, Hellgren K, Agardh E . Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients. Acta Ophthalmol. 2007; 86(2):170-6. DOI: 10.1111/j.1600-0420.2007.01019.x. View

10.

Mayer M, Spiegler S, Ward B, Glucs A, Kim C . Mid-frequency loss of foveal flicker sensitivity in early stages of age-related maculopathy. Invest Ophthalmol Vis Sci. 1992; 33(11):3136-42. View

11.

Remky A, Arend O, Hendricks S . Short-wavelength automated perimetry and capillary density in early diabetic maculopathy. Invest Ophthalmol Vis Sci. 2000; 41(1):274-81. View

12.

Hood D, Benimoff N, Greenstein V . The response range of the blue-cone pathways: a source of vulnerability to disease. Invest Ophthalmol Vis Sci. 1984; 25(7):864-7. View

13.

Wild J, Hudson C . The attenuation of blue-on-yellow perimetry by the macular pigment. Ophthalmology. 1995; 102(6):911-7. DOI: 10.1016/s0161-6420(95)30935-9. View

14.

Midena E, Segato T, Blarzino M, Degli Angeli C . Macular drusen and the sensitivity of the central visual field. Doc Ophthalmol. 1994; 88(2):179-85. DOI: 10.1007/BF01204616. View

15.

Atchison D, Lovie-Kitchin J, Swann P . Investigation of central visual fields in patients with age-related macular changes. Optom Vis Sci. 1990; 67(3):179-83. DOI: 10.1097/00006324-199003000-00006. View

16.

Greenstein V, Hood D, Ritch R, Steinberger D, Carr R . S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci. 1989; 30(8):1732-7. View

17.

Chylack Jr L, Wolfe J, Singer D, Leske M, Bullimore M, Bailey I . The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993; 111(6):831-6. DOI: 10.1001/archopht.1993.01090060119035. View

18.

Johnson C . Selective versus nonselective losses in glaucoma. J Glaucoma. 2009; 3 Suppl 1:S32-44. View

19.

Remky A, Elsner A . Blue on yellow perimetry with scanning laser ophthalmoscopy in patients with age related macular disease. Br J Ophthalmol. 2005; 89(4):464-9. PMC: 1464837. DOI: 10.1136/bjo.2004.050260. View

20.

Steinmetz R, Haimovici R, Jubb C, Fitzke F, Bird A . Symptomatic abnormalities of dark adaptation in patients with age-related Bruch's membrane change. Br J Ophthalmol. 1993; 77(9):549-54. PMC: 513948. DOI: 10.1136/bjo.77.9.549. View